CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

By M. L. Brandi, R. Gagel, A. Angeli, J. Bilezikian, P. Beck‐Peccoz, C. Bordi, B. Conte‐Devolx, A. Falchetti, R. G. Gheri, A. Libroia and 14 more. 2001

1,640 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Oncology

View Paper: https://www.semanticscholar.org/paper/2953f9aa861b9fbcbaa9682bc0f6b915b25213d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Lemos

Citations in the corpus

• Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene (2008, methodology): “…may be undertaken in children within the first decade because tumors have developed in some children by the age of 5 years [Stratakis et al., 2000], and appropriate intervention in the form of biochemical testing, or treatment, or both, has been considered [Lips et al., 1984; Brandi et al., 2001].”